Performance analysis of BridgeBio Oncology Therapeutics Inc Com (BBOT)
Annual Return
Since Aug 12, 2025, BBOT has had an average annual return of -13.55%, underperforming the benchmark SPY, which returned +17.97% annual.
| 2026 | 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -32.75% | +29.74% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.39% | -14.42% | -10.77% | -6.04% | +6.66% | -15.05% | +10.50% | -32.75% | |||||
| 2025 | -7.36% | +29.53% | +3.11% | +3.10% | +1.71% | +29.74% |
Drawdown analysis of BridgeBio Oncology Therapeutics Inc Com (BBOT)
The maximum drawdown for the BBOT was -48.14%, occurring on Jun 10, 2026. This drawdown has not yet recovered.
The current BBOT drawdown is -38.68%.
Since Aug 12, 2025 BBOT has experienced the following drawdowns:
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 2 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -48.14% | Nov 17, 2025 | 140 | Jun 10, 2026 | Ongoing | Ongoing | Ongoing |
| -26.82% | Aug 18, 2025 | 4 | Aug 22, 2025 | 20 | Sep 22, 2025 | 24 |
| -15.72% | Oct 6, 2025 | 12 | Oct 22, 2025 | 13 | Nov 10, 2025 | 25 |
| -6.98% | Sep 22, 2025 | 1 | Sep 23, 2025 | 7 | Oct 2, 2025 | 8 |
| -2.90% | Nov 11, 2025 | 2 | Nov 13, 2025 | 1 | Nov 14, 2025 | 3 |
| -0.64% | Oct 2, 2025 | 1 | Oct 3, 2025 | 1 | Oct 6, 2025 | 2 |